Platelet inhibition with the glycoprotein IIb/IIIa receptor antagonist Lamifiban in high risk patient subsets: Studies to determine the correlation between platelet-mediated prothrombotic activity and clinical risk
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- October 21, 1997
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Cardiovascular System & Hematology (Science Metrix)
published in
- Circulation Journal